Truvestments Capital LLC - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 134 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
Truvestments Capital LLC ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,337
+36.2%
1,3640.0%0.01%
+57.1%
Q2 2023$14,936
+25.6%
1,3640.0%0.01%
+16.7%
Q1 2023$11,894
+36.4%
1,364
-1.9%
0.01%
+20.0%
Q4 2022$8,722
+74.4%
1,391
-6.5%
0.01%
+66.7%
Q3 2022$5,000
+25.0%
1,4870.0%0.00%
+50.0%
Q2 2022$4,000
+100.0%
1,487
+104.5%
0.00%
+100.0%
Q4 2021$2,000
-33.3%
7270.0%0.00%
-50.0%
Q3 2021$3,0000.0%7270.0%0.00%0.0%
Q2 2021$3,0000.0%7270.0%0.00%0.0%
Q1 2021$3,000
+200.0%
727
+127.9%
0.00%
+100.0%
Q4 2020$1,0000.0%3190.0%0.00%0.0%
Q2 2020$1,000
-66.7%
319
-42.8%
0.00%
-50.0%
Q3 2019$3,000
-25.0%
558
-10.3%
0.00%
-33.3%
Q2 2019$4,000
-50.0%
6220.0%0.00%
-50.0%
Q1 2019$8,000
+14.3%
622
-2.5%
0.01%
+100.0%
Q3 2018$7,0006380.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Saturn V Capital Management LP 1,629,464$14,208,92610.61%
Lynx1 Capital Management LP 1,369,927$11,945,7639.96%
Versant Venture Management, LLC 543,753$4,741,5269.88%
Foresite Capital Management IV, LLC 1,787,094$15,583,4608.09%
Octagon Capital Advisors LP 4,570,918$39,858,4055.74%
ACUTA CAPITAL PARTNERS, LLC 878,500$7,660,5205.64%
TCG Crossover Management, LLC 3,048,257$26,580,8015.18%
Affinity Asset Advisors, LLC 1,083,118$9,444,7893.12%
Altium Capital Management LP 620,000$5,406,4003.00%
Bain Capital Life Sciences Investors, LLC 2,500,000$21,8002.72%
View complete list of CYMABAY THERAPEUTICS INC shareholders